Filing Flows › Onconetix (ONCO) › Q1 2026 › vs Q1 2025
Onconetix (ONCO) Q1 2026 vs Q1 2025 (year over year)
Onconetix's revenue fell $80K (-79%) from $102K in Q1 2025 to $21K in Q1 2026.
Onconetix, Q1 2026: revenue $21K (-79% year over year), net loss $4.2M, operating cash flow −$2.1M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $21K | $102K | −$80K | -79% |
| Other income, net | $6.0M | $4.0M | $2.0M | +49% |
| Net loss | $4.2M | $8.5M | −$4.3M | -51% |
| Costs & expenses | $10.2M | $12.7M | −$2.4M | -19% |
| Operating costs | $10.2M | $12.7M | −$2.4M | -19% |
| SG&A | $2.0M | $1.7M | $365K | +22% |
| Other operating costs | $8.2M | $10.9M | −$2.7M | -25% |
| Operating cash sources | $4.2M | $8.5M | −$4.3M | -51% |
| Depreciation & amortization | $5K | $5K | $1K | +14% |
| Share-based compensation | $22K | $29K | −$7K | -24% |
| Working capital & other | $2.1M | $6.5M | −$4.4M | -68% |
| Cash used in operations | $2.1M | $2.0M | $122K | +6% |
| Net loss absorbed | $4.2M | $8.5M | −$4.3M | -51% |
Questions
How much did Onconetix's revenue grow year over year in Q1 2026?
Onconetix's revenue fell $80K (-79%) from $102K in Q1 2025 to $21K in Q1 2026.